Related News
-
His Holiness Karekin II Joins…
Friday, July 30, 2010
LOS ANGELES -- His Holiness Karekin II, Supreme Patriarch and Catholicos of All Armenians, became the latest potential… more...
-
Kaysville Rallies to Help…
Friday, July 30, 2010
KAYSVILLE -- In March, Davis Cox played in a four-day baseball tournament, then spent time with his family hikingA few… more...
-
Alexion Hoping Its Soliris Is…
Friday, July 16, 2010
Every biopharmaceutical company hopes to discover, develop and bring to market a wonder drug that can treat many… more...
-
Family Faces Financial…
Friday, July 16, 2010
Cynthia Vale only sees her 1-year-old son Isaac on the weekends. During the week, she spends her time at Texas Children… more...
-
Dylan Fights for Life
Thursday, July 8, 2010
A two-year-old Taunton boy was given the gift of life by his twin sister after doctors described him as the sickest… more...
News
-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
More News
-
Drug Resistance Threatens New Sleeping…
Cape Town -- Hopes for an effective new combination treatment for sleeping sickness have… more...
-
His Holiness Karekin II Joins ABMDR as…
LOS ANGELES -- His Holiness Karekin II, Supreme Patriarch and Catholicos of All Armenians… more...
-
FDA Drug Safety Communication:…
The U.S. Food and Drug Administration (FDA) is informing patients and healthcare… more...
-
CytRx's Tamibarotene Eradicates Former…
LOS ANGELES -- CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing… more...
-
TNF Blockers May Increase the Risk of…
The Food and Drug Administration (FDA) received reports of malignancies in children using… more...
Treatment News
AA&MDSIF Bone Marrow Failure Scientific Symposium March 11-12, 2010
| More
Monday, January 4, 2010
By Alice Houk
Registration is now open for the second Bone Marrow Failure Disease Scientific Symposium to be held March 11 - 12, 2010 at the Bethesda Hyatt Hotel in Bethesda, Maryland.
The symposium is being presented by the Aplastic Anemia & MDS International Foundation and sponsored by the NIH National Heart, Lung and Blood Institute and Office of Rare Diseases Research.
This symposium will bring together physicians treating these diseases and laboratory researchers studying the immunology and cell biology of bone marrow failure to discuss current areas of controversy, share recent research results, and propose specific recommendations for the highest priority directions for basic and clinical research needed to advance the field. Topics will include:
Poster sessions and networking opportunities will also be included in the program. The cost is $150 per registrant and includes all meals and program materials.
For more information about the symposium registration, agenda, speakers and poster session submissions, visit the AA&MDSIF website at www.AAMDS.org/symposium2010.
Source: Aplastic Anemia & MDS International Foundation
Log in to comment.